These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1768 related articles for article (PubMed ID: 20591140)

  • 21. Multi-system reproductive metabolic disorder: significance for the pathogenesis and therapy of polycystic ovary syndrome (PCOS).
    Li Y; Chen C; Ma Y; Xiao J; Luo G; Li Y; Wu D
    Life Sci; 2019 Jul; 228():167-175. PubMed ID: 31029778
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The polycystic ovary syndrome: a position statement from the European Society of Endocrinology.
    Conway G; Dewailly D; Diamanti-Kandarakis E; Escobar-Morreale HF; Franks S; Gambineri A; Kelestimur F; Macut D; Micic D; Pasquali R; Pfeifer M; Pignatelli D; Pugeat M; Yildiz BO;
    Eur J Endocrinol; 2014 Oct; 171(4):P1-29. PubMed ID: 24849517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polycystic ovary syndrome, obesity and reproductive implications.
    Hirschberg AL
    Womens Health (Lond); 2009 Sep; 5(5):529-40; quiz 541-2. PubMed ID: 19702452
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiovascular risk in women with polycystic ovary syndrome.
    Giallauria F; Orio F; Palomba S; Lombardi G; Colao A; Vigorito C
    J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):987-92. PubMed ID: 18799960
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome: diagnostic and methodological challenges.
    Jeanes YM; Reeves S
    Nutr Res Rev; 2017 Jun; 30(1):97-105. PubMed ID: 28222828
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic Syndrome: Polycystic Ovary Syndrome.
    Mortada R; Williams T
    FP Essent; 2015 Aug; 435():30-42. PubMed ID: 26280343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polycystic ovary syndrome: a review for primary providers.
    Buccola JM; Reynolds EE
    Prim Care; 2003 Dec; 30(4):697-710. PubMed ID: 15024892
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polycystic ovary syndrome: reviewing diagnosis and management of metabolic disturbances.
    Spritzer PM
    Arq Bras Endocrinol Metabol; 2014 Mar; 58(2):182-7. PubMed ID: 24830595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Psychological distress, anger and quality of life in polycystic ovary syndrome: associations with biochemical, phenotypical andsocio-demographic factors.
    Borghi L; Leone D; Vegni E; Galiano V; Lepadatu C; Sulpizio P; Garzia E
    J Psychosom Obstet Gynaecol; 2018 Jun; 39(2):128-137. PubMed ID: 28385114
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endocrine and metabolic characteristics in polycystic ovary syndrome.
    Glintborg D
    Dan Med J; 2016 Apr; 63(4):. PubMed ID: 27034186
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cutaneous Findings and Systemic Associations in Women With Polycystic Ovary Syndrome.
    Schmidt TH; Khanijow K; Cedars MI; Huddleston H; Pasch L; Wang ET; Lee J; Zane LT; Shinkai K
    JAMA Dermatol; 2016 Apr; 152(4):391-8. PubMed ID: 26720591
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polycystic ovary syndrome: update on diagnosis and treatment.
    Setji TL; Brown AJ
    Am J Med; 2014 Oct; 127(10):912-9. PubMed ID: 24859638
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Uterovaginal agenesis and polycystic ovary syndrome: psychological disturbance in adolescence].
    Laggari V; Christogiorgos S; Deligeoroglou E; Tsiantis J; Creatsas G
    Psychiatriki; 2012; 23(3):203-11. PubMed ID: 23073543
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Female Pelvic Conditions: Polycystic Ovary Syndrome.
    Wilkinson LD; Brady PH; Gin GT; Rosenblum E
    FP Essent; 2022 Apr; 515():26-31. PubMed ID: 35420404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Obesity and polycystic ovary syndrome.
    Naderpoor N; Shorakae S; Joham A; Boyle J; De Courten B; Teede HJ
    Minerva Endocrinol; 2015 Mar; 40(1):37-51. PubMed ID: 25411807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polycystic ovary syndrome and female reproduction.
    Elghblawi E
    Br J Nurs; 2007 Oct 11-24; 16(18):1118-21. PubMed ID: 18073681
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The cardiometabolic effect of current management of polycystic ovary syndrome: strategies of prevention and treatment.
    Baldani DP; Skrgatic L; Ougouag R; Kasum M
    Gynecol Endocrinol; 2018 Feb; 34(2):87-91. PubMed ID: 28944709
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Managing polycystic ovary syndrome in primary care.
    Lua ACY; How CH; King TFJ
    Singapore Med J; 2018 Nov; 59(11):567-571. PubMed ID: 30498839
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polycystic ovary syndrome (PCOS) and hyperandrogenism: the role of a new natural association.
    Morgante G; Cappelli V; Di Sabatino A; Massaro MG; De Leo V
    Minerva Ginecol; 2015 Oct; 67(5):457-63. PubMed ID: 26491824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lifestyle and Behavioral Management of Polycystic Ovary Syndrome.
    Brennan L; Teede H; Skouteris H; Linardon J; Hill B; Moran L
    J Womens Health (Larchmt); 2017 Aug; 26(8):836-848. PubMed ID: 28570835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 89.